Addcontentitemstostore Request

{
  "summary": "PUT /contentStores/{contentStore}/items request - Request body",
  "description": "Add store items",
  "value": "{\n  \"items\": [\n    {\n      \"URL\": \"https://www.economist.com/business/2025/03/27/how-safe-is-your-dna-in-a-bankruptcy\",\n      \"creationDate\": \"2025-03-31T12:45:17.748Z\",\n      \"description\": \"23andMe\u2019s demise raises thorny legal questions\",\n      \"hash\": \"98f33be71f927141ca5a12e74985f0bc\",\n      \"id\": \"article-1-id\",\n      \"image\": \"https://www.economist.com/content-assets/images/20250329_WBD002.jpg\",\n      \"inStock\": true,\n      \"lastModifiedDate\": \"2025-03-31T12:45:17.748Z\",\n      \"name\": \"How safe is your DNA in a bankruptcy?\",\n      \"properties\": [\n        {\n          \"id\": \"category\",\n          \"values\": [\n            \"Business\"\n          ]\n        },\n        {\n          \"id\": \"creator\",\n          \"values\": [\n            \"The Economist\"\n          ]\n        }\n      ],\n      \"publicationDate\": \"2025-03-27T15:46:32.000Z\",\n      \"text\": \"Spit in a tube and, for about 100 USD, discover secrets held by your DNA. That was the promise of 23andMe, a direct-to-consumer genetic-testing company. It proved popular\u2014more than 15m customers coughed up to receive tailored reports. Insights ranged from the banal (there is a 48% chance you have freckles) to the potentially helpful (you have an increased risk of type-2 diabetes). Ultimately, though, the venture was unprofitable. On March 23rd the firm filed for bankruptcy.\"\n    },\n    {\n      \"URL\": \"https://www.economist.com/technology-quarterly/2025/02/21/editing-pigs-mice-and-mosquitoes-may-save-lives\",\n      \"creationDate\": \"2025-03-31T12:45:17.748Z\",\n      \"description\": \"But there are possible pitfalls\",\n      \"hash\": \"7c0419a5660ada4663a2959070a88973\",\n      \"id\": \"article-2-id\",\n      \"image\": \"https://www.economist.com/content-assets/images/20250301_TQD006.jpg\",\n      \"inStock\": true,\n      \"lastModifiedDate\": \"2025-03-31T12:45:17.748Z\",\n      \"name\": \"Editing pigs, mice and mosquitoes may save lives\",\n      \"properties\": [\n        {\n          \"id\": \"category\",\n          \"values\": []\n        },\n        {\n          \"id\": \"creator\",\n          \"values\": [\n            \"The Economist\"\n          ]\n        }\n      ],\n      \"publicationDate\": \"2025-02-21T17:47:17.000Z\",\n      \"text\": \"ON MARCH 15th 2024, a dark brown, gene-edited pig was driven from its home in the Midwest to a medical facility on the outskirts of Boston, Massachusetts. It had never before been outside the clean room in which it had spent its year-long life. The next day the pig had its kidneys removed. One was for research; the other was transplanted into a man called Richard Slayman. It was the first pig-to-human kidney transplant with a living patient. In the operating theatre at Mass General Hospital, after the surgical team were finished, invited attendees spontaneously clapped.\"\n    }\n  ]\n}"
}